M. Kathleen Behrens - 27 Jan 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Cristin L. Rothfuss, as Attorney-in-Fact for M. Kathleen Behrens
Issuer symbol: SRPT
Transactions as of: 27 Jan 2026
Net transactions value: -$16.98
Form type: 4
Filing time: 29 Jan 2026, 20:04:03 UTC
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BEHRENS M KATHLEEN	Director	215 FIRST STREET, SUITE 415, CAMBRIDGE	/s/ Cristin L. Rothfuss, as Attorney-in-Fact for M. Kathleen Behrens	29 Jan 2026	0001211701

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Options Exercise	$143,955	+10,500	+5.4%	$13.71	203,976	27 Jan 2026	Direct
transaction	SRPT	Common Stock	Tax liability	$143,972	-6,494	-3.2%	$22.17	197,482	27 Jan 2026	Direct	F1
holding	SRPT	Common Stock						10,000	27 Jan 2026	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Options Exercise	$0	+10,500		$0.000000	0	27 Jan 2026	Common Stock	10,500	$13.71	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer.